The March edition of Research News is here! Learn about:
🆕 Our new Black Health Equity strategy
💰 New funding opportunities
💙 How our research makes a real impact for men with #ProstateCancer
📰 Recent prostate cancer research articles
Read here: buff.ly/8Sd6vxh
Scientific paper published in BMJ Open, titled "Protocol for the PROSECCA study: a new approach for predicting radiotherapy outcome using artificial intelligence and electronic population-based healthcare data" written by Nailon et al.
Could AI predict outcomes and side-effects of radiotherapy in men with #prostatecancer?
Prostate Cancer UK funded Prof. Bill Nailon and Prof. Duncan McLaren @edinburgh-uni.bsky.social detail how they'll answer this question in BMJ Open.
Grab a ☕ and read: bmjopen.bmj.com/content/16/2...
A great edition of the newsletter to start the year!
If you have any thoughts or feedback on our impact assessment please let us know!
#impact #ImpactAssessment #research
Scientific Review Paper published in Expert Opinion on Therapeutic Targets, titled: Blocking glycan production by targeting GALNT7 for prostate cancer therapy. Written by Peng et al.
Could GALNT7 be a promising therapeutic target for #ProstateCancer?
A team led by Dr Jennifer Munkley @newcastleuni.bsky.social explores the enzyme's role & emerging strategies to inhibit its activity, writing in Expert Opinion on Therapeutic Targets.
Grab a ☕ & read: doi.org/10.1080/1472...
Professor Johann de Bono and Dr Adam Sharp stand side by side, looking at a computer screen displaying prostate tissue.
The December edition of Research News is here! Find out about:
🔬 An exciting research project.
💻 A new webinar series.
🩺 UK Prostate Cancer Clinical Research Strategy Group.
💬 Discussion session topic at From Ideas to Innovation.
📚 Read it here: buff.ly/kXTXjdx
Could machine learning be a future tool to predict protein-protein interactions in #ProstateCancer?
A team including Prostate Cancer UK funded Dr Ke Yuan @uofgcancersciences.bsky.social take protein language models a step forward in @natcomms.nature.com.
Grab a ☕ and read: doi.org/10.1038/s414...
Dr Joaquin Mateo was a research fellow @icr.ac.uk interested in making personalised #ProstateCancer treatments.
In 2014, we funded him to see if men with specific DNA mutations responded favourably to a drug called olaparib.
📙 Read more: prostatecanceruk.org/research/res...
Great to see this poster out! Congrats to @asachdeva.bsky.social and team!
Careers in Research Webinar. Clinical Trials Units: Elevating Research for Real-World Impact. Tuesday 13 January 2026, 1-2pm (online). Professor Emma Hall and Claire Snowdon. The Institute of Cancer Research - Clinical Trials and Statistics Unit (ICR-CTSU).
📢Careers in Research Webinar📢
🤔Got a great idea, but not sure how to turn it into a clinical trial?
📉Curious about careers in trials – stats, methods, data?
Register to explore how partnering with a CTSU can support researchers at every stage 👇
events.teams.microsoft.com/event/2b9a0b...
Could CAR-T cells carrying collagen targeted IL-12 be a safe therapy for #ProstateCancer?
A team including Prostate Cancer UK fellow @Ko1ssk.bsky.social & Jun Ishihara @imperialcollegeldn.bsky.social share new results in @natbiomedeng.nature.com.
Grab a ☕ and read:
doi.org/10.1038/s415...
Great to see this group up and running.
If you work in clinical prostate cancer research please help us spread the word and amplify amongst your network!
Picture of Prostate Cancer UK volunteer team at Tour de 4.
The October edition of Research News is here! Read more about:
🚴 Tour de 4.
🤝 Upcoming meetings and webinars.
🌱 A personal development resource.
🗣️ Speakers at our researcher event, From Ideas to Innovation.
💰 Funding opportunities.
📖 Read it here: prostatecanceruk.org/research/for...
Great to see the room packed and to hear the buzz ahead of the ‘Optimising outcomes in advanced prostate cancer’ at #ESMO25
Peter Godolphin on stage at ESMO25 with his acknowledgement slide showing funders including Prostate Cancer UK
Great to see @prostatecanceruk.bsky.social funded work being presented at #ESMO25
Congrats to Peter Godolphin and team from @ucl.ac.uk and @mrcctu.bsky.social
Our fantastic @prostateukprofs.bsky.social career development fellow @juanjimenezvacas.bsky.social takes a closer look at a potential new treatment approach for #ProstateCancer that has stopped responding to existing therapies ⬇️.
It's an excellent scheme for establishing connections in your research areas, and it creates opportunities for potential future collaborations. James Thetford, Mentee. University of Surrey.
I am enthusiastic about providing help to ensure researchers succeed and thrive. Professor Jason Carroll, Mentor. University of Cambridge.
🤝Our mentoring scheme brings #ProstateCancer researchers from different institutions together.
🚀To help navigate challenges & build successful careers - delivering maximum impact for men.
💪Together, we're building a stronger, more connected, research community.
prostatecanceruk.org/research/for...
👇A great opportunity to work on exciting new #ProstateCancer research in the brilliant @bevanlab.bsky.social
Professor Gerhardt Attard holding a pipette.
The September edition of Research News is here! Find out more about:
💊 Exciting Research Findings.
🤝 Researcher Mentoring Scheme.
🏆 A Researcher Achievement.
💻 Upcoming New Seminar Series.
💰 Funding Opportunities.
📖 Read it here: prostatecanceruk.org/research/for...
I'm looking forward to meeting like-minded researchers and hearing about all the exciting advances in prostate cancer research. Dr Sarah Gosling, Prostate Cancer UK Fellow.
Exciting🌟From Ideas to Innovation🌟Updates!
👩🔬Sessions chaired by Prostate Cancer UK Career Acceleration Fellows.
🎤30 brilliant researchers sharing Research Snapshots.
🚀All #ProstateCancer researchers welcome.
🗓️Check the webpage for agenda & registration.
👇
prostatecanceruk.org/research/for...
Scientific Paper Published in The Journal of the American Medical Association, titled: Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial. Written by Ng et al.
Could faster MRI scans allow more men to receive timely #ProstateCancer diagnoses?
Research published in @jama.com led by @veerukasi.bsky.social, Dr Alex Ng & Dr Aqua Asif at @ucl.ac.uk compares the efficacy of shortened versus standard-length scans.
Grab a ☕ & read: doi.org/10.1001/jama...
Scientific Paper Published in Cell, titled: Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers. Written by Grist et al.
Could transcriptome signatures identify men with advanced #ProstateCancer most likely to benefit from chemotherapy?
A brilliant team led by Prof Gerhardt Attard @ucl.ac.uk share exciting new findings in @cp-cell.bsky.social.
Grab a ☕ and read: doi.org/10.1016/j.ce...
Picture showing two of the PACE-NODES trial team, Prof Emma Hall and Dr Angela Pathmanathan.
The August edition of Research News is here! Read more about:
📈 The PACE-NODES clinical trial.
🗣️ Speakers at our researcher event, From Ideas to Innovation.
💰 Funding opportunities.
🌍 An exciting upcoming conference.
📖 Read it here: prostatecanceruk.org/research/for...
Why does #ProstateCancer risk increase with age?
An international collaboration including Dr. Justin Sturge @hyms.ac.uk uncovers a mechanism involving key target Endo180, writing in NPJ Aging.
Grab a ☕ and read: doi.org/10.1038/s415...
![Scientific Paper Published in Endocrine Oncology, titled: Thieno[2,3-b]pyridine compounds potently inhibit prostate cancer growth and motility. Written by Alkheilewi et al.](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:dewxxsnm5un65f4aivqn4aph/bafkreica6ggdtsvfvujqtb4qmbc2ecc5fhzikvgcxexgarqa6qypxnq4zq)
Scientific Paper Published in Endocrine Oncology, titled: Thieno[2,3-b]pyridine compounds potently inhibit prostate cancer growth and motility. Written by Alkheilewi et al.
Could a new class of drugs be an effective treatment option for #ProstateCancer?
A team including many of our funded researchers @universityofessex.bsky.social and @imperialcollegeldn.bsky.social share exciting new findings in Endocrine Oncology.
Grab a ☕ and read: doi.org/10.1530/EO-2...
If you can’t sponsor me please like and repost to spread the word, including this link to @prostatecanceruk.bsky.social risk checker:
prostatecanceruk.org/risk-checker
One more ride in the bank!
I think I enjoyed it, although I was a bit surprised I managed 49miles!!
Conquered a few hills too.
Just keep peddling! 🚴♀️
We @prostatecanceruk.bsky.social are proud to have supported this study. 💙
Although no clear survival benefit was found it's encouraging to see reduction in side effects.
Congratulations to @mrcctu.bsky.social and everyone involved!
Can metabolic imaging help identify more aggressive forms of #ProstateCancer?
A team @cuh.nhs.uk led by Dr Tristan Barrett, @FerdiaGallagher.bsky.social and Dr Nikita Sushentsev focus on improving detection of cribriform disease, writing in @pnas.org.
Grab a ☕ and read: doi.org/10.1073/pnas...
